
Biotech’s Mega-Deal Monday: Novartis’ $12B Avidity Buy, Novo-Pfizer Obesity War, and AI Partnerships Reshape the Sector
Healthcare markets exploded with deal-making activity as November opened with a bang. Novartis dropped $12 billion to acquire Avidity Biosciences, Novo Nordisk and Pfizer escalated








